NON-HODGKINS LYMPHOMA
Clinical trials for NON-HODGKINS LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new NON-HODGKINS LYMPHOMA trials appear
Sign up with your email to follow new studies for NON-HODGKINS LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise against tough blood cancers
Disease control Recruiting nowThis study tests an experimental oral drug called MK-1026 (nemtabrutinib) in people with certain blood cancers, including chronic lymphocytic leukemia, non-Hodgkin lymphoma, and Waldenstrom's macroglobulinemia. The goal is to see if the drug can shrink or control the cancer and t…
Matched conditions: NON-HODGKINS LYMPHOMA
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
New drug combo offers hope for Tough-to-Treat blood cancers
Disease control Recruiting nowThis study is for adults with two types of blood cancer—T-PLL or NHL—that have not responded to or have returned after previous treatments. Researchers are testing a new drug called APG-115, either alone or combined with another drug APG-2575, to find the safest dose and see if i…
Matched conditions: NON-HODGKINS LYMPHOMA
Phase: PHASE2 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated Jun 10, 2026 13:24 UTC